A novel polymorphism of the gene encoding furin, a TGF-β1 activator, and the influence on cardiac allograft vasculopathy formation

Transplant Immunology

Volumn 13, Issue 3, 2004, Pages 185-190

  Densem, C G ^a,c   Mutlak, A S M ^b   Pravica, V ^b   Brooks, N H ^a   Yonan, N ^a   Hutchinson, I V ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Cardiac transplantation; Furin; Transforming growth factor 1; Vasculopathy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; FURIN; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ANGIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE IDENTIFICATION; GENE ISOLATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HEART TRANSPLANTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; VASCULAR DISEASE;

ADULT; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; FURIN; GREAT BRITAIN; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

EID: 4744370492     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.04.005     Document Type: Article

References (40)

1. Little D.M., Haynes L.D., Alam T., Geraghty J.G., Sollinger H.W., Hullett D.A. Does transforming growth factor beta 1 play a role in the pathogenesis of chronic allograft rejection? Transplant Int. 12:1999;393-401
2. Aziz T., Haselton P., Wynn Hann A., Yonan N., Deiraniya A., Hutchinson I.V. Transforming growth factor-beta in relation to cardiac allograft vasculopathy after heart transplantation. J Thorac Cardiovasc Surg. 119:2000;700-708
3. Aziz T., Saad R.A., Burgess M., Yonan N., Hasleton P., Hutchinson I.V. Transforming growth factor beta and myocardial dysfunction following heart transplantation. Eur J Cardio-thorac Surg. 20:2001;177-186
4. Densem C.G., Hutchinson I.V., Cooper A., Yonan N., Brooks N.H. Polymorphism of the Transforming Growth Factor-Beta 1 gene correlates with the development of Coronary Vasculopathy following Cardiac Transplantation. J Heart Lung Transplant. 19:2000;551-556
5. El-Gamel A., Sim E., Hasleton P., Hutchinson J., Yonan N., Egan J., et al. Transforming growth factor beta (TGF-b) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant. 18:1999;828-837
6. El- Gamel A., Awad M.R., Sim E., Haselton P., Yonan N., Egan J., et al. Transforming growth factor-β1 and lung allograft fibrosis. Eur J Cardio-thorac Surg. 13:1998;424-430
7. Demirci G., Nashan B., Pichlmayr R. Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3. Transplantation. 62:1996;1776-1783
8. Sankaran D., Asharaf S., Asderakis A., Roberts I.S., Short C.D., Dyer P.A., et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int. 56:1999;281-289
9. Ravalli S., Szabolcs M., Albala A., Michler R.E., Cannon P.J. Increased immunoreactive endothelin-1 in human transplant coronary artery disease. Circulation. 94:1996;2096-2102
10. Simonson M.S., Robinson A.V., Schulak J.A., Hricik D.E. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine. Transplantation. 73:2002;1054-1059
11. Schalken J.A., Roebroek A.J.M., Oomen P.P.C.A., Wagenaar S.S.C., Debruynk F.M.J., Van De Ven W.J.M. Fur gene expression as a discriminating marker for small cell and non-small cell lung carcinomas. J Clin Invest. 80:1987;1545-1549
12. Barr P.J., Manson O.B., Landsberg K.E., Wong P.A., Kiffer M.C., Brake A.J. cDNA and gene structure for a human subtilisin-like protease with cleavage specificity for paired basic amino acid residues. DNA Cell Biol. 10:1991;319-328
13. Hatsuzawa K., Murakami K., Nakayama K. Molecular and enzymaticproperties of furin, a Kex2-like endoprotease involved in the precursor cleavage at Arg-X-Lys/Arg-Arg sites. J Biochem. 111:1992;296-301
14. Beaubien G., Schafer M.K., Weihe E., Dong W., Chretien M., Seidah N.G., et al. The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates. Cell Tissue Res. 279:1995;539-549
15. Dubois C.M., Laprise M.H., Blanchette F., Gentry L.E., Leduc R. Processing of TGF-β1 precursor by human furin convertase. J. Biol. Chems. 270:1995;10 618-10 624
16. Blanchette F., Day R., Dong W., Laprise M.H., Dubois C.M. TGF-beta1 regulates gene expression of its own converting enzyme. J Clin Invest. 99:1997;1974-1983
17. Denault J.B., Claing A., D'Orleans-Juste P., Sawamura T., Kido T., Masaki T., et al. Processing of proendothelin-1 by human furin convertase. FEBS Lett. 362:1995;276-280
18. Negishi M., Lu D., Zhang Y.-Q., Sawada Y., Sasaki T., Kayo T., et al. Upregulatory expression of furin and transforming growth factor-β by fluid shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 21:2001;785
19. Misumi Y., Sohad M., Ikehara Y. Sequences of the cDNA encoding rat furin, a possible propeptide-processing endoprotease. Nucl Acid Res. 18:1990;6719
20. Van Den Ouweland A.M.W., Van Duijnhoven H.L.P., Keizer G.D., Dorssers L.C.J., Van de Ven W.J. Structural homology between the human fur gene product and the subtilisin-like protease encoded by yeast KEX2. Nucl Acid Res. 18:1990;664
21. Turner D., Grant S.C.D., Yonan N., Sheldon S., Dyer P.A., Sinnot P.J., et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation. 64:1997;776-779
22. Awad M.R., Turner D.M., Sinnott P.J., Hutchinson I.V. Polymorphism in the TGF- β1 gene. Eur J Immunogenetics. 24:1997;45
23. Wilson A.G., di Giovine F.S., Blakemore A.I.F., Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF α) gene detectable by Ncol. Hum Mol Genet. 1:1992;353
24. Rosenthal A., Chamock J.D.S. New protocol for DNA sequencing with dye terminators. DNA Seq. 3:1992;61-64
25. Johnson D.E., Alderman E.L., Schroeder J.S., Gao S.Z., Hunt S., DeCampli W.M., et al. Transplant coronary artery disease: Histopathological correlations with angiographic morphology. J Am Coll Cardiol. 17:1991;449-457
26. Olivari M.T., Homans D.C., Wilson R.F., Kubo S.H., Ring W.S. Coronary artery disease in cardiac transplant patients receiving triple drug immunosuppressive therapy. Circulation. 80:(Suppl III):1989;III-111-115
27. Grainger D.J., Kemp P.R., Witchell C.M., Weissberg P.L., Metcalfe J.C. TGF-beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cAMP before entry into M phase. Biochem J. 299:1994;227-235
28. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 83:1986;4167-4171
29. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci SA. 90:1993;770-774
30. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G., Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 90:1992;1582-1592
31. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against transforming growth factor-β1 suppresses intimal hyperplasia in a rat model. J Clin Invest. 93:1994;1172-1178
32. Majesky M.W., Lindner V., Twardzik D.R., Schwartz S.M., Reidy M.A. Production of Transforming Growth Factor β1 during Repair of Arterial Injury. J Clin Invest. 88:1991;904-910
33. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA. 84:1987;5788-5792
34. Majack R.A. Beta-type transforming growth factor specifies organizational behaviour in vascular smooth muscle cell cultures. J Cell Biol. 105:1987;465-471
35. Battegay E.J., Raines E.W., Seifert R.A., Bowen-Pope D.F., Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 63:1990;515-524
36. Koglin J., Glysing-Jensen T., Raisanen-Sokolowski A., Russell M.E. immune sources of transforming growth factor-β1 reduce transplant arteriosclerosis: Insight derived from a knockout mouse model. Circ Res. 83:1998;652-660
37. de Groot-Kruseman H.A., Baan C.C., Mol W.M., Niesters H.G.M., Maat A.P.W.M., Balk A.H.M.M., et al. Upregulated transforming growth factor-β1 expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation. Transplant Proc. 31:1999;2724-2725
38. Ayoubi T.A.Y., Creemers J.W.M., Roebroek A.J.M., Van de van W.J.M. Expression of the dibasic proprotein processing enzymes furin is directed by multiple promoters. J Biol Chem. 296:1994;9298-9303
39. Roebroek A.J.M., Schalken J.A., Bussemakers J.G., Heeikhuizen H., Onnekink C., Debruyne F.M.J., Bloemers H.P.J., et al. Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene. Mol Biol Rep. 11:1986;117-125
40. Dubois C.M., Blanchette F., Laprise M.-H., Leduc R., Grondin F., Seidah N.G. Evidence that Furin Is an Authentic Transforming Growth Factor-β1-Converting Enzyme. Am J Pathol. 158:2001;305-316